SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-358925
Filing Date
2017-12-01
Accepted
2017-12-01 16:16:02
Documents
4
Period of Report
2017-12-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d450624d8k.htm 8-K 21921
2 EX-5.1 d450624dex51.htm EX-5.1 10039
3 EX-10.1 d450624dex101.htm EX-10.1 12047
4 GRAPHIC g450624g53j78.jpg GRAPHIC 1879
  Complete submission text file 0001193125-17-358925.txt   47874
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 171234364
SIC: 2834 Pharmaceutical Preparations